NLRP3 INFLAMMASOM HEMMER

European patent · EP4363406 · In force

Register entry

Publication number
EP4363406
Application number
EP22744149
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 1, 2022
Published
May 8, 2024
Granted
Sep 10, 2025
Protection ends at the latest
Jun 30, 2042
Next annual fee due
Jul 31, 2027
IPC classes
C07D 237/34 (2006.01)
C07D 471/04 (2006.01)
Priority
US 202163217970 P 02.07.2021
PCT application
PCT/EP2022/068292 01.07.2022
PCT publication
WO2023/275366 05.01.2023
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Jul 22, 2026

    Change

    Published in Swissreg on 22.07.2026

  3. Nov 11, 2025

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 11.11.2025

  4. Sep 10, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 10.09.2025

Parties

Inventor

JOHANSSON, Lars Anders Mikael

151 Södertälje, SE

GRADÉN, Henrik

151 Södertälje, SE

BERGONZINI, Giulia

151 Södertälje, SE

SUGAMA, Hiroshi

Osaka-shi, Osaka 541-8505, JP

MATSUMURA, Takehiko

Osaka-shi, Osaka 541-8505, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.